ITVISMA® (onasemnogene abeparvovec-brve)
| Full Name | ITVISMA® (onasemnogene abeparvovec-brve) |
| Drug | onasemnogene abeparvovec-brve |
| Manufacturer | Novartis Gene Therapy |
| Route of Administration | Intrathecal |
| Site of Care | Healthcare Facility |
| Approved Indication | The treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in SMN1 gene |
| Disease | Spinal Muscular Atrophy (SMA) |
| Therapeutic Area | Neurology; Cell & Gene Therapy |
| Enrollment Form | Enrollment Form |
| Phone Number | 800-697-5048 |
| Fax Number | 877-471-5704 |
| Website | itvisma.com |
| Patient Resources | Cure SMA and Muscular Dystrophy Association |